Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Moderna Plunges 11% as EU Vaccine Deal Lacks Minimum Purchase Guarantee
Moderna stock dropped 11.3% after the EU's RSV vaccine deal lacked a minimum purchase commitment, adding to investor worries about sales and cash burn.
Rivian Stock Bounces Back 18% Above Share Sale Price, But Dilution and Cash Burn Loom
Rivian stock rose 0.7% to $18.24 after a filing confirmed full exercise of underwriters' option in its discounted stock sale, raising $1.32 billion. The stock now trades 18% above the offer price, but dilution and cash burn issues remain.
SpaceX Plunges $154B in Four Days Post Nasdaq-100 Inclusion
SpaceX shares dropped 2.2% to $148.74, erasing $154 billion in equity since its Nasdaq-100 inclusion, far exceeding the $4.3 billion in passive buying.
Jiuzi Holdings Surges on AI Deal Target, 90x Volume Stuns Market
Jiuzi Holdings (JZXN) stock surged 101.7% after revealing plans for an AI imaging deal targeting $1 million in profit, but the 90x turnover rate stole the spotlight.
MARA Holdings Slips After Texas Deal Cap, Tenant Uncertainty
MARA Holdings dropped 5.5% Friday, giving back most of Thursday's gains, after an SEC filing revealed a $600 million ceiling for its Texas project buyout.
Global Mofy AI Shares Surge 117% as Trading Volume Explodes
Global Mofy AI (GMM) surged 117% on Friday, with 107 million shares changing hands, far exceeding its typical volume, amid a low share count post-reverse split.
BAE Systems Shares Edge Up as Investors Eye July 30 Earnings and Valuation Premium
BAE Systems shares edged up 0.5% on Friday, recovering slightly after three straight declines. The stock remains down 8.7% for the week as investors look ahead to July 30 half-year results.
Rolls-Royce Buyback Progress Fails to Lift Shares Despite Analyst Optimism
Rolls-Royce (LON:RR) fell 0.5% to 1,429p as its £1.34 billion buyback failed to support the stock. Jefferies raised its price target to 1,870p, but investors are waiting for a guidance hike.